TipRanks
M3 Inc (MTHRF)
OTHER OTC:MTHRF
US Market
MTHRF
M3
RESEARCH TOOLSreports

M3 (MTHRF) Stock Forecast & Price Target

9 Followers
See the Price Targets and Ratings of:

MTHRF Analyst Ratings

Hold
8Ratings
Hold
2 Buy
6 Hold
0 Sell
Based on 8 analysts giving stock ratings to
M3
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

MTHRF Stock 12 Month Forecast

Average Price Target

$12.74
▲(15.84% Upside)
Based on 8 Wall Street analysts offering 12 month price targets for M3 in the last 3 months. The average price target is $12.74 with a high forecast of $18.07 and a low forecast of $10.65. The average price target represents a 15.84% change from the last price of $11.00.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"7":"$7","10":"$10","13":"$13","16":"$16","19":"$19"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":18.0677745,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$18.07</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":12.7425357,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$12.74</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":10.6504776,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$10.65</span>\n  </div></div>","useHTML":true}}],"tickPositions":[7,10,13,16,19],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,11.6,12.097521115384614,12.59504223076923,13.092563346153845,13.59008446153846,14.087605576923076,14.585126692307691,15.082647807692307,15.580168923076922,16.077690038461537,16.575211153846155,17.07273226923077,17.570253384615384,{"y":18.0677745,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,11.6,11.687887361538461,11.775774723076923,11.863662084615385,11.951549446153846,12.039436807692308,12.127324169230768,12.21521153076923,12.303098892307691,12.390986253846153,12.478873615384614,12.566760976923076,12.654648338461538,{"y":12.7425357,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,11.6,11.526959815384615,11.45391963076923,11.380879446153847,11.307839261538462,11.234799076923077,11.161758892307692,11.088718707692308,11.015678523076923,10.942638338461538,10.869598153846153,10.79655796923077,10.723517784615385,{"y":10.6504776,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":13.587,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.1,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.247,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.321,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.989,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.188,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.75,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.54,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.92,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.9,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.15,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.4,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.6,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$18.07Average Price Target$12.74Lowest Price Target$10.65
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Morgan Stanley Analyst forecast on MTHRF
Ryotaro Hayashi
Morgan Stanley
Morgan Stanley
$13.31
Hold
21.03%
Upside
Reiterated
10/02/26
Morgan Stanley Remains a Hold on M3 (MTHRF)
J.P. Morgan Analyst forecast on MTHRF
Naoko Saito
J.P. Morgan
J.P. Morgan
$13.95
Buy
26.79%
Upside
Reiterated
09/25/26
Analysts Are Bullish on Top Healthcare Stocks: Abeona Therapeutics (ABEO), M3 (MTHRF)
Nomura Analyst forecast on MTHRF
Unknown Analyst
Nomura
Not Ranked
Nomura
$17.75→$18.07
Buy
64.25%
Upside
Reiterated
09/17/26
M3 (MTHRF) Gets a Buy from Nomura
Daiwa Analyst forecast on MTHRF
Unknown Analyst
Daiwa
Not Ranked
Daiwa
$11.41
Hold
3.74%
Upside
Reiterated
09/10/26
Daiwa Remains a Hold on M3 (MTHRF)
UBS Analyst forecast on MTHRF
Unknown Analyst
UBS
Not Ranked
UBS
$12.05
Hold
9.50%
Upside
Downgraded
08/25/26
UBS downgrades M3 (MTHRF) to a Hold
Citi Analyst forecast on MTHRF
Unknown Analyst
Citi
Not Ranked
Citi
$13.31→$11.41
Hold
3.74%
Upside
Downgraded
08/17/26
M3 (MTHRF) was downgraded to a Hold Rating at Citi
Tokai-Tokyo Securities Analyst forecast on MTHRF
Unknown Analyst
Tokai-Tokyo Securities
Not Ranked
Tokai-Tokyo Securities
$10.65
Hold
-3.18%
Downside
Reiterated
08/12/26
Tokai-Tokyo Securities Sticks to Their Hold Rating for M3 (MTHRF)
Goldman Sachs Analyst forecast on MTHRF
Akinori Ueda
Goldman Sachs
Goldman Sachs
$11.09
Hold
0.86%
Upside
Reiterated
08/07/26
Goldman Sachs Keeps Their Hold Rating on M3 (MTHRF)
SMBC Nikko Analyst forecast on MTHRF
Unknown Analyst
SMBC Nikko
Not Ranked
SMBC Nikko
$12.68
Buy
15.26%
Upside
Reiterated
06/02/26
M3 (MTHRF) Receives a Buy from SMBC Nikko
Jefferies Analyst forecast on MTHRF
Miyabi Yamakita
Jefferies
Jefferies
$10.14
Hold
-7.79%
Downside
Reiterated
05/28/26
Analysts Offer Insights on Healthcare Companies: Phreesia (NYSE: PHR), M3 (Other OTC: MTHRF) and Eisai Co (Other OTC: ESALF)
Mizuho Securities Analyst forecast on MTHRF
Unknown Analyst
Mizuho Securities
Not Ranked
Mizuho Securities
$16.48→$11.28
Hold
2.59%
Upside
Reiterated
02/17/26
Mizuho Securities Keeps Their Hold Rating on M3 (MTHRF)
Bank of America Securities Analyst forecast on MTHRF
Unknown Analyst
Bank of America Securities
Not Ranked
Bank of America Securities
$16.48
Buy
49.84%
Upside
Reiterated
01/28/26
Bank of America Securities Sticks to Its Buy Rating for M3 (MTHRF)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Morgan Stanley Analyst forecast on MTHRF
Ryotaro Hayashi
Morgan Stanley
Morgan Stanley
$13.31
Hold
21.03%
Upside
Reiterated
10/02/26
Morgan Stanley Remains a Hold on M3 (MTHRF)
J.P. Morgan Analyst forecast on MTHRF
Naoko Saito
J.P. Morgan
J.P. Morgan
$13.95
Buy
26.79%
Upside
Reiterated
09/25/26
Analysts Are Bullish on Top Healthcare Stocks: Abeona Therapeutics (ABEO), M3 (MTHRF)
Nomura Analyst forecast on MTHRF
Unknown Analyst
Nomura
Not Ranked
Nomura
$17.75→$18.07
Buy
64.25%
Upside
Reiterated
09/17/26
M3 (MTHRF) Gets a Buy from Nomura
Daiwa Analyst forecast on MTHRF
Unknown Analyst
Daiwa
Not Ranked
Daiwa
$11.41
Hold
3.74%
Upside
Reiterated
09/10/26
Daiwa Remains a Hold on M3 (MTHRF)
UBS Analyst forecast on MTHRF
Unknown Analyst
UBS
Not Ranked
UBS
$12.05
Hold
9.50%
Upside
Downgraded
08/25/26
UBS downgrades M3 (MTHRF) to a Hold
Citi Analyst forecast on MTHRF
Unknown Analyst
Citi
Not Ranked
Citi
$13.31→$11.41
Hold
3.74%
Upside
Downgraded
08/17/26
M3 (MTHRF) was downgraded to a Hold Rating at Citi
Tokai-Tokyo Securities Analyst forecast on MTHRF
Unknown Analyst
Tokai-Tokyo Securities
Not Ranked
Tokai-Tokyo Securities
$10.65
Hold
-3.18%
Downside
Reiterated
08/12/26
Tokai-Tokyo Securities Sticks to Their Hold Rating for M3 (MTHRF)
Goldman Sachs Analyst forecast on MTHRF
Akinori Ueda
Goldman Sachs
Goldman Sachs
$11.09
Hold
0.86%
Upside
Reiterated
08/07/26
Goldman Sachs Keeps Their Hold Rating on M3 (MTHRF)
SMBC Nikko Analyst forecast on MTHRF
Unknown Analyst
SMBC Nikko
Not Ranked
SMBC Nikko
$12.68
Buy
15.26%
Upside
Reiterated
06/02/26
M3 (MTHRF) Receives a Buy from SMBC Nikko
Jefferies Analyst forecast on MTHRF
Miyabi Yamakita
Jefferies
Jefferies
$10.14
Hold
-7.79%
Downside
Reiterated
05/28/26
Analysts Offer Insights on Healthcare Companies: Phreesia (NYSE: PHR), M3 (Other OTC: MTHRF) and Eisai Co (Other OTC: ESALF)
Mizuho Securities Analyst forecast on MTHRF
Unknown Analyst
Mizuho Securities
Not Ranked
Mizuho Securities
$16.48→$11.28
Hold
2.59%
Upside
Reiterated
02/17/26
Mizuho Securities Keeps Their Hold Rating on M3 (MTHRF)
Bank of America Securities Analyst forecast on MTHRF
Unknown Analyst
Bank of America Securities
Not Ranked
Bank of America Securities
$16.48
Buy
49.84%
Upside
Reiterated
01/28/26
Bank of America Securities Sticks to Its Buy Rating for M3 (MTHRF)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ONCBeOne Medicines
OVIDOvid Therapeutics
ASNDAscendis Pharma
QNCXQuince Therapeutics
EHCEncompass Health
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering M3

3 Months
OpenAI Medical - Healthcare Information ServicesTipRanks - OpenAI
Success Rate
2/4 ratings generated profit
50%
Average Return
+3.38%
Copying OpenAI Medical - Healthcare Information Services's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +3.38% per trade.
1 Year
OpenAI Medical - Healthcare Information ServicesTipRanks - OpenAI
Success Rate
2/4 ratings generated profit
50%
Average Return
+5.03%
Copying OpenAI Medical - Healthcare Information Services's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +5.03% per trade.
2 Years
OpenAI Medical - Healthcare Information ServicesTipRanks - OpenAI
Success Rate
2/4 ratings generated profit
50%
Average Return
+5.03%
Copying OpenAI Medical - Healthcare Information Services's trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of +5.03% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MTHRF Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
4
4
2
2
2
Buy
3
4
2
2
1
Hold
3
3
6
6
6
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
10
11
10
10
9
In the current month, MTHRF has received 3 Buy Ratings, 6 Hold Ratings, and 0 Sell Ratings. MTHRF average Analyst price target in the past 3 months is 12.74.
Each month's total comprises the sum of three months' worth of ratings.

MTHRF Financial Forecast

MTHRF Earnings Forecast

Next quarter’s earnings estimate for MTHRF is $0.12 with a range of $0.11 to $0.14. The previous quarter’s EPS was $0.09. MTHRF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year MTHRF has Performed in-line its overall industry.
Next quarter’s earnings estimate for MTHRF is $0.12 with a range of $0.11 to $0.14. The previous quarter’s EPS was $0.09. MTHRF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year MTHRF has Performed in-line its overall industry.

MTHRF Sales Forecast

Next quarter’s sales forecast for MTHRF is $589.91M with a range of $571.09M to $625.79M. The previous quarter’s sales results were $569.26M. MTHRF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year MTHRF has Performed in-line its overall industry.
Next quarter’s sales forecast for MTHRF is $589.91M with a range of $571.09M to $625.79M. The previous quarter’s sales results were $569.26M. MTHRF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year MTHRF has Performed in-line its overall industry.

MTHRF Stock Forecast FAQ

What is MTHRF’s average 12-month price target, according to analysts?
Based on analyst ratings, M3 Inc’s 12-month average price target is 12.74.
    What is MTHRF’s upside potential, based on the analysts’ average price target?
    M3 Inc has 15.84% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is MTHRF a Buy, Sell or Hold?
          M3 Inc has a consensus rating of Hold which is based on 2 buy ratings, 6 hold ratings and 0 sell ratings.
            What is M3 Inc’s price target?
            The average price target for M3 Inc is 12.74. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $18.07 ,the lowest forecast is $10.65. The average price target represents 15.84% Increase from the current price of $11.
              What do analysts say about M3 Inc?
              M3 Inc’s analyst rating consensus is a Hold. This is based on the ratings of 8 Wall Streets Analysts.
                How can I buy shares of MTHRF?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.